id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2003-P-0346-0002,FDA,FDA-2003-P-0346,"Proposed Rule re Microbiology Devices; Reclassification of Hepatitis A Virus (HAV) Serological Assays (IgM Antibody, IgG Antibody and Total Antibodies [IgM and IgG])",Proposed Rule,NPR-Notice of Proposed Rule-Making,2004-09-30T04:00:00Z,2004,9,2004-09-29T04:00:00Z,2004-12-30T04:59:59Z,2024-11-25T16:34:43Z,69FR58371,0,0,0900006480496e02